Latest News in the pharma Industry

Research & Development

Merck's Keytruda receives FDA approval to treat patients with refractory classical Hodgkin lymphoma

Merck's Keytruda receives FDA approval to treat patients with refractory classical Hodgkin lymphoma

15 Mar 2017

Only anti-PD-1 therapy approved for the treatment of patients with difficult-to-treat cHL regardless of prior stem cell transplantation or use of brentuximab vedotin

Read more 
Metrion and Concept introduce integrated ion channel drug discovery service

Metrion and Concept introduce integrated ion channel drug discovery service

15 Mar 2017

Supports small molecule ion channel drug discovery, from initial screening to development candidate.

Read more 
Allergan and Editas Medicine all set to discover and develop CRISPR genome editing medicines for eye diseases

Allergan and Editas Medicine all set to discover and develop CRISPR genome editing medicines for eye diseases

14 Mar 2017

Alliance brings together eye care and CRISPR innovators to develop transformative medicines for patients.

Read more 
Repatha demonstrates reduced need for apheresis in patients with high LDL-C in study

Repatha demonstrates reduced need for apheresis in patients with high LDL-C in study

13 Mar 2017

Data suggest an alternative option for patients.

Read more 
Boehringer's investigational anti-CD33 monoclonal antibody gains orphan drug designation for treatment of myelodysplastic syndromes

Boehringer's investigational anti-CD33 monoclonal antibody gains orphan drug designation for treatment of myelodysplastic syndromes

13 Mar 2017

BI 836858 was previously granted orphan drug designation for the treatment of patients with AML.

Read more 
Proclara Biosciences Australia awarded grant to help develop new biotherapy with blockbuster potential

Proclara Biosciences Australia awarded grant to help develop new biotherapy with blockbuster potential

12 Mar 2017

Work on a second-generation fusion protein due to start in 2017 at Patheon's manufacturing facility in Brisbane.

Read more 
Bavarian Nordic announces collaboration to evaluate CV301 and Tecentriq in bladder cancer

Bavarian Nordic announces collaboration to evaluate CV301 and Tecentriq in bladder cancer

12 Mar 2017

Collaboration is the second to evaluate a combination of CV301 with a checkpoint inhibitor.

Read more 
Horizon Discovery enters into R&D and licensing partnership for bioproduction cell line optimisation

Horizon Discovery enters into R&D and licensing partnership for bioproduction cell line optimisation

9 Mar 2017

Partnership formed to evaluate the impact of Amplycell’s novel cell fitness technology on expression capacity of Horizon’s bioproduction cell line.

Read more 
FDA accepts sNDA for Vraylar

FDA accepts sNDA for Vraylar

8 Mar 2017

Application seeks to expand Vraylar label to include Phase III clinical data for the maintenance treatment of schizophrenia.

Read more 
Novartis' Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause

Novartis' Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause

7 Mar 2017

Cosentyx has shown superior and sustained results versus both Stelara and Enbrel, delivering long-lasting clear or almost clear skin.

Read more 
Vertex to acquire CTP-656 from Concert Pharmaceuticals for the treatment of cystic fibrosis

Vertex to acquire CTP-656 from Concert Pharmaceuticals for the treatment of cystic fibrosis

6 Mar 2017

Vertex to develop CTP-656 for potential use in future combination regimens aimed at treating the underlying cause of CF.

Read more 
GSK study shows Nucala significantly improves quality of life and lung function in severe asthma patients

GSK study shows Nucala significantly improves quality of life and lung function in severe asthma patients

6 Mar 2017

Provides hope for patients with severe asthma, who currently have very limited treatment options.

Read more